Product Information

OLMESARTAN MEDOXOMIL 40 MG TAB is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.1083 per EA under NDC 82009007590. Its NADAC has been published 136 times since Jan 17, 2024.

FDA first approved this application on Apr 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMESARTAN MEDOXOMIL 40 MG TAB

Olmesartan Medoxomil
$0.1083per EA

Strength

40 mg/1

NDC

82009007590

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OLMESARTAN MEDOXOMIL

Approval Type

Generic (ANDA)

FDA Application

ANDA204798

FDA Approved

4/24/2017

TE Code

AB

On Market Since

8/1/2023

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for OLMESARTAN MEDOXOMIL 40 MG TAB has been published 136 times since Jan 17, 2024, and over the history we have for it it has declined 13.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1083 per EA
All-time high$0.1357 (Apr 10, 2024)
All-time low$0.1083 (Aug 19, 2026)
52-week high$0.1235
52-week low$0.1083
Median price$0.1226
Average price$0.1215
Largest weekly change+18.1% (Jun 19, 2024)
Weeks tracked136
Tracking sinceJan 17, 2024

Price History

1W

-1.0%

1M

-1.0%

3M

-5.3%

6M

-12.3%

1Y

-11.5%

3Y

N/A

5Y

N/A

All

-13.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OLMESARTAN MEDOXOMIL 40 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 40 MG TAB, manufactured by Quallent Pharmaceuticals Health LLC, is $0.1083 per EA (NDC 82009007590), effective Aug 19, 2026.

How has the price of OLMESARTAN MEDOXOMIL 40 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 40 MG TAB has declined 13.9%. It has been tracked across 136 weekly CMS publications since Jan 17, 2024.

What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 40 MG TAB?

Since Jan 17, 2024, the NADAC for OLMESARTAN MEDOXOMIL 40 MG TAB has ranged from a low of $0.1083 (Aug 19, 2026) to a high of $0.1357 (Apr 10, 2024), with a median of $0.1226 per EA.

Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 40 MG TAB?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN MEDOXOMIL 40 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures OLMESARTAN MEDOXOMIL 40 MG TAB?

OLMESARTAN MEDOXOMIL 40 MG TAB (NDC 82009007590) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.